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Abstract
Macrophages are known to be involved in pathogen recognition
and mediate host immune responses, but, in the clinical setting,
their purported central role in opportunistic fungal infections
has not been demonstrated to date. Herein, we describe a
patient with invasive testicular aspergillosis in whom we found,
for the ﬁrst time, a defect in macrophage function.
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Opportunistic fungal infections are encountered in the set-
ting of immunocompromised hosts. This has been well
described in patients who have received induction chemo-
therapy for leukaemia or who are undergoing haematopoietic
stem cell transplantation, as well as in those receiving
immunosuppressive drugs such as corticosteroids [1].
Immune recognition of Aspergillus fumigatus is mediated by an
array of pattern recognition receptors (PRRs) present on
macrophages, neutrophils and other host immune cells. Toll-
like receptor (TLR)2, TLR4 and the C-type lectin receptor
Dectin-1 are the major PRRs that recognize A. fumigatus [2]
and consequently activate the host defence mechanisms. The
indispensable role assumed by neutrophils in defence against
the fungi is readily highlighted by the increased risk of asper-
gillosis in patients with prolonged neutropenia [1,3]. How-
ever, to date, the purported key role played by macrophages
has not been demonstrated in the clinical setting. This
because, in contrast to the relative ease with which neutro-
phil counts can be obtained, quantiﬁcation of macrophage
numbers and function in the patient is challenging.
On a similar note, postoperative aspergillosis has been
described [4], but the underlying pathophysiology remains
unknown. We recently managed an 80-year-old man who
had testicular aspergillosis following urethrotomy [5]. The
patient had a history of post-injection gluteal abscess caused
by Acremonium species, but was otherwise not known to be
immunocompromised. Nonetheless, given the atypical disease
presentation in this setting, functional assays were performed
to assess the response of the patient’s immune cells to the
fungal pathogen.
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from the patient (during voriconazole treatment) and
from healthy controls by density centrifugation, as previously
described [6]. Differentiation of monocyte-derived macro-
phages (MDMs) was performed with either 10% human
pooled serum, macrophage colony-stimulating factor (M-CSF)
or granulocyte–macrophage colony-stimulating factor (GM-
CSF) [7]. The cells were stimulated with the respective
fungal components (live conidia and inactivated A. fumigatus
hyphal strain V05-27, 1 · 106/mL, and Acremonium kiliense,
1 · 106/mL) or speciﬁc PRR ligands (TLR2 ligand Pam3Cys
(10 lg/mL), TLR4 ligand Escherichia coli lipopolysaccharide
(LPS) (2 ng/mL) and Dectin-1 ligand b-glucan (10 lg/mL)) for
24 or 48 h at 37C. Interleukin (IL)-6 and tumour necrosis
factor (TNF)-a concentrations (at 24 h) and interferon
(IFN)-c concentrations (at 48 h) were measured with com-
mercial ELISA kits. Cell membrane expression of TLR2,
TLR4 and Dectin-1 were analysed with a FACSCalibur ﬂow
cytometer.
Production of TNF-a and IL-6 by the patient’s PBMCs in
response to both live and heat-inactivated Aspergillus was
normal (Fig. 1a). In contrast, serum-differentiated MDMs
from the patient had markedly diminished TNF-a and IL-6
levels as compared with controls (Fig. 1b). There was no
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases
RESEARCH NOTES MYCOLOGY
difference in IFN-c-inducing capability between patient and
control cells (data not shown). We studied this deﬁcient
response in MDMs by speciﬁcally differentiating PBMCs into
type 1 or type 2 macrophages with growth factors. The use
of M-CSF in the process of MDM differentiation gives rise to
type 2-like resident macrophages, whereas GM-CSF-differen-
tiated MDMs have type 1-like proinﬂammatory macrophage
characteristics [8,9]. The defect was further delineated as
being a dysfunction in the GM-CSF-differentiated MDM
response. As compared with both young and elderly healthy
controls, GM-CSF-differentiated MDMs of the patient
showed diminished TNF-a and IL-6 responses, not only to
Aspergillus, but also to Acremonium species, relative to the M-
CSF-differentiated MDMs. In addition, GM-CSF-derived mac-
rophages displayed deﬁcient cytokine production following
stimulation with Pam3Cys, LPS and b-glucan, which are spe-
ciﬁc ligands for the TLR2, TLR4 and Dectin-1 receptors,
respectively (Fig. 1c,d shows TNF-a results; the data for IL-6
were similar to those for TNF-a, and are not shown). On
the other hand, M-CSF-differentiated macrophages of the
patient showed normal production of proinﬂammatory cyto-
kines.
In tandem with the functional responses elicited as above,
morphologically the patient’s macrophages also showed poor
differentiation under the inﬂuence of GM-CSF, yielding smal-
ler cells than controls (Fig. 2a–c). In addition, ﬂow cytomet-
ric analysis of the GM-CSF-differentiated macrophages
revealed reduced TLR2, TLR4 and Dectin-1 expression rela-
tive to the controls (Fig. 2d–f).
The above ﬁndings point to a defect in inﬂammatory mac-




























































































FIG. 1. (a, b) Cytokine response upon stimulation of (a) peripheral blood mononuclear cells (PBMCs) and (b) pooled serum-differentiated
monocyte-derived macrophages (MDMs) of the patient and three healthy controls with live Aspergillus conidia and heat-inactivated hyphae (HK
hyphae). (c, d) Tumour necrosis factor-a (TNF-a) response upon stimulation of (c) macrophage colony-stimulating factor (M-CSF)-differentiated
and (d) granulocyte–macrophage colony-stimulating factor (GM-CSF)-differentiated MDMs from patient, three young healthy controls and three
elderly healthy controls with the respective ligands as indicated. The data are expressed as means ± standard errors of the mean. IL, interleukin;
LPS, lipopolysaccharide.
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described and linked to susceptibility to a locally invasive
Aspergillus infection.
Conventionally, in the setting of invasive aspergillosis, tis-
sue macrophages are known to form the ﬁrst line of host
defence, whereas the role of neutrophils predominates fol-
lowing Aspergillus conidial germination [10]. However, until
now, the role of macrophages in defence against Aspergillus
infection has not be demonstrated in vivo [11]. On the other
hand, the clinical association between neutropenia and inva-
sive aspergillosis is well established in haematological patients
[3]. Hohl et al. have described how the time to recruitment
of neutrophils may be an important determinant of infection
outcome in a mouse model of pulmonary invasive aspergillo-
sis. Notably, alveolar macrophage-depleted mice did not
seem to have increased susceptibility to inhaled Aspergillus
conidia challenge [12]. However, the central role of macro-
phages in coordinating the host inﬂammatory response and
its antigen-presenting capabilities cannot be disregarded.
Our patient exhibited a defect in the differentiation of
type 1 (GM-CSF-induced) proinﬂammatory macrophages,
which are believed to be recruited during the inﬂamma-
tion process [8,9]. This is in contrast to the type 2
(M-CSF-induced) ‘resident’ macrophages, which act as
immune sentinels in the tissues. The inability to mount an
adequate proinﬂammatory TNF-a and IL-6 response here
was attributable to deﬁcient expression of the major PRRs
that are primarily responsible for immune recognition of
A. fumigatus: TLR2, TLR4 and Dectin-1. This may partly be
attributable to a failure of proper differentiation into type 1
macrophages, as supported by the small size of the patient’s
cells following GM-CSF induction (Fig. 2a). Incidentally, the
patient’s GM-CSF-differentiated MDMs had also exhibited
diminished cytokine responses with hindsight of his past his-
tory of Acremonium abscess. Furthermore, the attenuated
immunity elicited from the patient while on antifungal
treatment takes on added signiﬁcance, as voriconazole, con-
versely, is known to heighten TNF-a and nuclear factor-jB
production [13]. Immune senescence was a consideration
that had led us to include healthy elderly controls in our
ex vivo studies. However, it was apparent that age was not a
signiﬁcant factor in determining susceptibility in this case, as
the macrophages of the patient also had lower production of
cytokines when compared with cells isolated from elderly
control volunteers (Fig. 1c,d).
Putting the above ﬁndings into perspective, it is believed
















FIG. 2. (a, c) Direct microscopy of granulocyte–macrophage colony-stimulating factor (GM-CSF)-differentiated monocyte-derived macrophages
(MDMs) from (a) the patient, (b) a healthy young control and (c) a healthy elderly control (Leica direct viewing microscope series, ·400 magniﬁ-
cation). (d, f) Histogram overlay of (d) Toll-like receptor (TLR)2, (e) TLR4 and (f) Dectin-1 receptor expression on GM-CSF-differentiated
MDMs of the patient (grey shade), a healthy young control (continuous line) and a healthy elderly control (dotted line).
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acquired immune system might have compensated for the
inﬂammatory macrophage dysfunction in the patient [14], an
invasive procedure had facilitated the inoculation of an
opportunistic pathogen deep beyond the epithelium and the
sentinel capabilities of resident macrophages. Nonetheless,
the infection was subsequently dealt with adequately by med-
ical intervention, as well as by the other intact arms of the
innate and acquired host immune response. This case adds
to our understanding of the relative clinical importance of
the role that macrophages play in invasive fungal infections.
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Abstract
This study determined the value of (1,3)-b-D-glucan (BDG), Can-
dida mannan (MN) and Candida species-speciﬁc DNA as surro-
gates for diagnosis of candidaemia. Thirty-nine patients yielding
Candida species in blood cultures were investigated for presence
of BDG, MN and Candida species-speciﬁc DNA in serum sam-
ples. The Candida spp. bloodstream isolates included C. albicans
(n = 16), C. tropicalis (n = 10), C. parapsilosis (n = 7), C. glabrata
(n = 3) and C. dubliniensis (n = 3). Positivity of the three markers
was as follows: Candida DNA for corresponding Candida species,
100%; BDG, 87%; MN, 59%. Despite varying sensitivities of these
biomarkers, they provided a useful adjunct to the diagnosis of
candidaemia.
Keywords: (1-3)-b-D-glucan, Candida DNA, Candida mannan,
candidaemia, diagnosis
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